DOI QR코드

DOI QR Code

Effects of host modulation by nonsteroidal anti-inflammatory drugs on periodontal disease: a systematic review and meta-analysis

비스테로이드성 항염증제를 이용한 숙주조절이 치주질환에 미치는 영향: 체계적 고찰 및 메타 분석

  • Kang, Dae-Young (Department of Periodontology, College of Dentistry, Dankook University) ;
  • Cho, In-Woo (Department of Periodontology, College of Dentistry, Dankook University) ;
  • Shin, Hyun-Seung (Department of Periodontology, College of Dentistry, Dankook University) ;
  • Ahn, Hyeong-Sik (Institute for Evidence-based Medicine, Department of Preventive Medicine, College of Medicine, Korea University) ;
  • Kim, Hyun-Jung (Institute for Evidence-based Medicine, Department of Preventive Medicine, College of Medicine, Korea University) ;
  • Park, Jung-Chul (Department of Periodontology, College of Dentistry, Dankook University)
  • 강대영 (단국대학교 치과대학 치주과학교실) ;
  • 조인우 (단국대학교 치과대학 치주과학교실) ;
  • 신현승 (단국대학교 치과대학 치주과학교실) ;
  • 안형식 (근거중심 의학연구소, 고려대학교 의과대학 예방의학교실) ;
  • 김현정 (근거중심 의학연구소, 고려대학교 의과대학 예방의학교실) ;
  • 박정철 (단국대학교 치과대학 치주과학교실)
  • Received : 2017.01.06
  • Accepted : 2017.03.09
  • Published : 2017.03.31

Abstract

Purpose: Nonsteroidal anti-inflammatory drugs that prohibit biosynthesis of arachidonic acid metabolites have been considered potent host modulation agents. The aim of this review was to determine the effect of nonsteroidal anti-inflammatory drugs adjunctive with nonsurgical periodontal treatment in patients with periodontal disease. Materials and Methods: Three electronic databases were searched to identify relevant studies. The methodological quality and mean differences of the change in clinical attachment level and probing depth were analyzed according to Cochrane review methods. Results: Twelve studies were included in the methodological assessment and nine studies were suitable for inclusion in the meta-analysis. The mean difference in the clinical attachment level gain did not differ significantly between the nonsteroidal anti-inflammatory drugs and control groups at any observation time. The highest mean difference in clinical attachment level gain was 0.30 mm at 4 weeks (95% confidence interval = -0.37 to 0.97). There was a significant mean difference in the probing depth reduction, of 0.34 mm (95% confidence interval = 0.29 to 0.40) at 6 weeks. Conclusion: Therefore, nonsteroidal anti-inflammatory drugs have additional therapeutic effect when administrated with nonsurgical periodontal treatment.

목적: 아라키돈산 대사물의 생합성을 억제하는 비스테로이드성 항염증제는 잠재적인 숙주조절제로 고려되고 있다. 이종설의 목적은 비스테로이드성 항염증제를 비외과적 치주치료와 병용하였을 때 치주질환자에 미치는 영향을 평가하는 데 있다. 연구 재료 및 방법: 관련된 연구를 확인하기 위하여 세 전자 데이터베이스를 검색하였다. Cochrane의 고찰 방법론에 따라 방법론적인 질, 임상 부착 수준과 탐침 깊이 변화량에 대한 평균 차이를 분석하였다. 결과: 총 12개의 연구의 방법론을 평가하였고 이중 9개의 연구에 대해 메타-분석을 시행하였다. 임상 부착 수준의 변화에 대한 평균차의 경우 모든 관찰기간에서 비스테로이드성 항염증제 군과 대조군간 유의차를 보이지 않았다. 가장 큰 평균차는 4주 때 0.30 mm로 나타났다(95% 신뢰구간 = -0.37 to 0.97). 탐침 깊이 변화에 대한 평균차는 6주 때 0.34 mm(95% 신뢰구간 = 0.29 to 0.40)로 유의차를 보였다. 결론: 이를 토대로 하였을 때 비스테로이드성 항염증제를 비외과적 치주치료와 병용하여 투여하였을 때 부가적으로 치료효과를 증대시킬 수 있을 것으로 생각된다.

Keywords

References

  1. Consensus report. Periodontal diseases: pathogenesis and microbial factors. Ann Periodontol 1996;1: 926-32. https://doi.org/10.1902/annals.1996.1.1.926
  2. Havemose-Poulsen A, Sorensen LK, Bendtzen K, Holmstrup P. Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2007; 78:475-92. https://doi.org/10.1902/jop.2007.060135
  3. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329-34. https://doi.org/10.2337/diacare.16.1.329
  4. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000;71:743-51. https://doi.org/10.1902/jop.2000.71.5.743
  5. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 2002;29 Suppl 2:6-16.
  6. Haffajee AD, Socransky SS, Ebersole JL. Survival analysis of periodontal sites before and after peri-odontal therapy. J Clin Periodontol 1985;12:553-67. https://doi.org/10.1111/j.1600-051X.1985.tb01389.x
  7. Giannobile WV, Braun TM, Caplis AK, Doucette-Stamm L, Duff GW, Kornman KS. Patient stratification for preventive care in dentistry. J Dent Res 2013;92:694-701. https://doi.org/10.1177/0022034513492336
  8. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997;14: 33-53. https://doi.org/10.1111/j.1600-0757.1997.tb00191.x
  9. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26(3 Pt 2):230-42. https://doi.org/10.1111/j.1600-0765.1991.tb01649.x
  10. Lane N, Armitage GC, Loomer P, Hsieh S, Majumdar S, Wang HY, Jeffcoat M, Munoz T. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005;76:1113-22. https://doi.org/10.1902/jop.2005.76.7.1113
  11. Leitao RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, Brito GA. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:956-63. https://doi.org/10.1902/jop.2005.76.6.956
  12. Martinez GL, Koury JC, Martins MA, Nogueira F, Fischer RG, Gustafsson A, Figueredo CM. Serum level changes of long chain-polyunsaturated fatty acids in patients undergoing periodontal therapy combined with one year of omega-3 supplementation: a pilot randomized clinical trial. J Periodontal Implant Sci 2014;44:169-77. https://doi.org/10.5051/jpis.2014.44.4.169
  13. Martuscelli G, Fiorellini JP, Crohin CC, Howell TH. The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog. J Periodontol 2000;71:573-8. https://doi.org/10.1902/jop.2000.71.4.573
  14. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-12. https://doi.org/10.1111/j.1600-0765.1986.tb01443.x
  15. Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-32. https://doi.org/10.1902/jop.2000.71.4.521
  16. Preshaw PM, Hefti AF, Novak MJ, Michalowicz BS, Pihlstrom BL, Schoor R, Trummel CL, Dean J, Van Dyke TE, Walker CB, Bradshaw MH. Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol 2004;75:1068-76. https://doi.org/10.1902/jop.2004.75.8.1068
  17. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003;8:12-37. https://doi.org/10.1902/annals.2003.8.1.12
  18. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions, vol. 5. Wiley Online Library, 2008.
  19. Opengrey. System for information on grey literature in Europe. Vandoeuvre-les-Nancy: Institut de l'Information Scientifique et Technique, 2011. Available from: http://www.opengrey.eu/ (updated 2015 Mar 11).
  20. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. https://doi.org/10.1902/annals.1999.4.1.1
  21. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-20. https://doi.org/10.1037/h0026256
  22. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. https://doi.org/10.1136/bmj.d5928
  23. Clinicaltrials.gov. A service of the U.S. National Institutes of Health. Bethesda: U.S. National Library of Medicine, 2000. Available from: https://clinicaltrials.gov/ (updated 2015 Apr 5).
  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. https://doi.org/10.1136/bmj.327.7414.557
  25. Aras H, Ca layan F, Guncu GN, Berbero lu A, Kilinc K. Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid. J Periodontol 2007;78:868-73. https://doi.org/10.1902/jop.2007.060412
  26. Azoubel MC, Sarmento VA, Cangussu V, Azoubel E, Bittencourt S, Cunha FQ, Ribeiro RA, Brito GA. Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis: short-term evaluation. J Periodontol 2008;79:1719-25. https://doi.org/10.1902/jop.2008.080019
  27. Buduneli N, Buduneli E, Cetin EO, Kirilmaz L, Kutukculer N. Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-beta levels following initial periodontal treatment and short-term meloxicam administration. Expert Opin Pharmacother 2010;11:1805-12. https://doi.org/10.1517/14656566.2010.490555
  28. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res 1991;26:415-21. https://doi.org/10.1111/j.1600-0765.1991.tb01731.x
  29. Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. J Periodontol 1998;69:772-6. https://doi.org/10.1902/jop.1998.69.7.772
  30. Ozgoren O, Develioglu H, Guncu G, Akman A, Berker E. The adjunctive effect of tenoxicam during non-surgical periodontal treatment on clinical parameters and gingival crevicular fluid levels of MMP-8 and TNF-alpha in patients with chronic periodontitis - randomized, double-blind clinical trial. Adv Clin Exp Med 2014;23:559-65. https://doi.org/10.17219/acem/37223
  31. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993;20:635-40. https://doi.org/10.1111/j.1600-051X.1993.tb00708.x
  32. Taiyeb Ali TB, Waite IM. The effect of systemic ibuprofen on gingival inflammation in humans. J Clin Periodontol 1993;20:723-8. https://doi.org/10.1111/j.1600-051X.1993.tb00697.x
  33. Vardar S, Baylas H, Huseyinov A. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis. J Periodontol 2003;74:57-63. https://doi.org/10.1902/jop.2003.74.1.57
  34. Knowles JW, Burgett FG, Nissle RR, Shick RA, Morrison EC, Ramfjord SP. Results of periodontal treatment related to pocket depth and attachment level. Eight years. J Periodontol 1979;50:225-33. https://doi.org/10.1902/jop.1979.50.5.225
  35. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J. Prevention of NSAIDinduced gastroduodenal ulcers. Cochrane Database Syst Rev 2002;4:CD002296.
  36. Slomiany BL, Slomiany A. Nonsteroidal antiinflammatory drugs impair oral mucosal repair by eliciting disturbances in endothelin-converting enzyme-1 and constitutive nitric oxide synthase. J Physiol Pharmacol 2001;52:81-92.
  37. Kotsakis GA, Thai A, Ioannou AL, Demmer RT, Michalowicz BS. Association between low-dose aspirin and periodontal disease: results from the continuous national health and nutrition examination survey (NHANES) 2011-2012. J Clin Periodontol 2015;42:333-41. https://doi.org/10.1111/jcpe.12380
  38. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005;32 Suppl 6:108-29. https://doi.org/10.1111/j.1600-051X.2005.00785.x
  39. Salvi GE, Lang NP. The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 2005;11:1757-69. https://doi.org/10.2174/1381612053764878
  40. Thomson WM, Williams SM. Partial- or full-mouth approaches to assessing the prevalence of and risk factors for periodontal disease in young adults. J Periodontol 2002;73:1010-4. https://doi.org/10.1902/jop.2002.73.9.1010

Cited by

  1. Melatonin as a Topical/Systemic Formulation for the Management of Periodontitis: A Systematic Review vol.14, pp.9, 2017, https://doi.org/10.3390/ma14092417